The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the ...

The work presented will be of interest to cancer biologists and more broadly to those interested in NSCLC translational studies. Non-small cell lung cancer (NSCLC) is the most common subtype of lung ...

This valuable study on strategies used by Pseudomonas to subvert hots immunity identifies a new immune evasion strategy. The study presents solid evidence on the cleavage of VgrG2B by Caspase 11 and ...

Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known ...

Key mechanism of resistance to BRAF-targeted melanoma therapy discovered. Potential for developing new cancer therapies with high efficacy by regulating polyamine biosynthesis to suppress resistance.

The study demonstrated that CD12 suppresses prostate cancers, and its loss drives AR and myelocytomatosis proto-oncogene (MYC ...

It helps prevent cancer cell proliferation by taking control of the cell cycle via suppressing the expression ... which provides instructions to make a protein involved in development of teeth, bones ...

PCNSL relapse was histologically confirmed in October 2021, with expression of CD20, BCL2, BCL6, MUM1, and c-Myc ... T-cell therapy. The first question is whether the observed T-cell proliferation ...

MYC is a transcription factor that plays relevant roles in cellular processes such as glycolysis, development, cell differentiation or proliferation. Recent research has associated the transcriptional ...